NTRB Stock Analysis: Buy, Sell, or Hold?
NTRB - Nutriband Inc. Common Stock
$2.85
-0.06 (-2.06%)
▼
5d:
-4.36%
30d:
-7.77%
90d:
-26.26%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Sep 08, 2026
Get Alerted When NTRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NTRB trading at deep discount. Market pricing in -9.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: NTRB trading at deep discount. Market pricing in -9.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.28
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$3.28
13.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NTRB is currently trading at $2.85, which is considered oversold relative to its 30-day fair value range of $2.95 to $3.13. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.0) compared to its historical average (2.6). Remarkably, the market is currently pricing in an annual earnings decline of 9.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NTRB is in a strong downtrend. The price is currently testing key support at $2.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.00 (+426.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NTRB is in a strong downtrend. The price is currently testing key support at $2.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.00 (+426.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.95 -
$3.13
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 426.3% below Wall St target ($15.00)
Trading Range Analysis
30-Day Trading Range
$2.95 -
$3.13
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.81
Resistance Level
$3.16
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.97
Wall Street Target
$15.00
(+426.3%)
Revenue Growth (YoY)
-35.1%
Valuation Discount vs History
-9.3% cheaper
PE vs Historical
2.0 vs 2.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.3%
(market-implied from PE analysis)
1-Year Target
$2.58
(-9%)
2-Year Target
$2.34
(-18%)
3-Year Target
$2.13
(-25%)
3-Yr Target (if PE normalizes)
(PE: 2→3)
$2.81
(-1%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.0 to 2.6
Stabilization Target:
$3.77
(+32.3%)
PE Expansion Potential:
+32.3%
Share & Embed Analysis
Last updated: August 02, 2026 6:11 AM ET
Data refreshes hourly during market hours. Next update: 7:11 AM
Data refreshes hourly during market hours. Next update: 7:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$819 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$33 | 58 HOLD |
